References in periodicals archive ?
The ethanolic (v/v) Cimicifuga racemosa dry extract Ze 450 was manufactured of dried rhizomes and roots and obtained from Max Zeller Soehne AG (Romanshorn, Switzerland).
Existe controversia sobre los estudios con la Cimicifuga racemosa, ya que ninguno de ellos ha sido realizado comparando contra placebo, sino con estrogenos conjugados 0.
In a previous study, the efficacy and tolerability of a standardised isopropanolic extract of the rootstock of Cimicifuga racemosa (iCR) (Remifemin, manufactured by Schaper & Bruemmer) was compared to tibolone (produced by Zizhu Pharm), a Selective Oestrogen Receptor Modulator (SERM) that has agonistic and/ or antagonist effect on oestrogen, progesterone and androgen receptors, in Chinese women aged 40-60 years with menopausal symptoms, in a randomised, double-blind, placebo-controlled study.
Osteoprotective effects of Cimicifuga racemosa and its triterpene-saponins are responsible for reduction of bone marrow fat.
Cimicifuga racemosa (CR) extracts are described in a monograph of the European Scientific Cooperative on Phytotherapy (ESCOP) as pharmacologically active treatment of climacteric symptoms (ESCOP 2003) and in the community herbal monograph of the Committee on Herbal Medicinal Products of the European Medicines Agency (EMA 2010) its well-established use status was granted.
Remifemin[R], an extract of Cimicifuga racemosa has been used in Germany for the relief of menopausal symptoms since the mid 1950s (Jellin 1999).
Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders.
Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief.
Cimicifuga racemosa (black cohosh) - Counters anxiety (anxiolytic) and is an antiinflammatory specific for muscular contraction headaches
Femular[R] one daily first thing (Flordis extract ZE450 of Cimicifuga racemosa rhizome, black cohosh)
Keywords: Ovariectomized rats Osteoporosis Adipocytes Cimicifuga racemosa Triterpene-saponins